Suppr超能文献

一项针对有肾小管损伤风险患者尿中配体蛋白的前瞻性研究。

A prospective study of urinary ligandin in patients at risk of renal tubular injury.

作者信息

Sherman R A, Feinfeld D A, Ohmi N, Arias I M, Levine S D

出版信息

Uremia Invest. 1984;8(2):111-5. doi: 10.3109/08860228409080992.

Abstract

The urinary excretion of ligandin, a proximal tubular enzyme and binding protein, was measured by radioimmunoassay in eight normals, six patients receiving radiocontrast media, and six patients in a critical care unit who were considered at high risk for acute renal failure. Ligandinuria was found to occur normally at rates under 5 micrograms/hr. In the patients receiving radiocontrast media, abnormal rates of ligandinuria were found in four patients. In 102 ligandin measurements in the critically ill patients, rates of ligandinuria exceeded normal only once (after contrast media exposure) despite 13 identifiable episodes of potentially nephrotoxic circumstances and two episodes of acute renal failure. Ligandinuria appears more sensitive as a marker for tubular injury from contrast media than from other renal insults.

摘要

通过放射免疫分析法对8名正常人、6名接受放射性造影剂的患者以及6名在重症监护病房且被认为有急性肾衰竭高风险的患者进行了检测,以测定近端肾小管酶和结合蛋白——配体结合蛋白的尿排泄量。发现正常情况下配体结合蛋白尿的发生率低于5微克/小时。在接受放射性造影剂的患者中,4名患者出现了异常的配体结合蛋白尿发生率。在对重症患者进行的102次配体结合蛋白测量中,尽管有13次可识别的潜在肾毒性情况发作以及2次急性肾衰竭发作,但配体结合蛋白尿发生率仅在1次(造影剂暴露后)超过正常水平。作为造影剂所致肾小管损伤的标志物,配体结合蛋白尿似乎比其他肾损伤更敏感。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验